Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
about
Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.Developments in Cardiac Resynchronisation Therapy.2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm AssociDevice therapies: new indications and future directions.High-density epicardial activation mapping to optimize the site for video-thoracoscopic left ventricular lead implant.Apical vs. non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis.Current Evidence and Recommendations for Cardiac Resynchronisation Therapy.Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patientsTargeting left ventricular lead placement to improve cardiac resynchronization therapy outcomes.Phrenic nerve stimulation in cardiac resynchronization therapy.Multisite left ventricular pacing in cardiac resynchronization therapy.Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.Avoiding non-responders to cardiac resynchronization therapy: a practical guide.Do cardiologists follow the European guidelines for cardiac pacing and resynchronization therapy? Results of the European Heart Rhythm Association survey.A comparison between radial strain evaluation by speckle-tracking echocardiography and cardiac magnetic resonance imaging, for assessment of suitable segments for left ventricular lead placement in cardiac resynchronization therapy.Acute haemodynamic comparison of multisite and biventricular pacing with a quadripolar left ventricular lead.Electrocardiographic patterns during left ventricular epicardial pacing.Analysis of Dyssynchrony and Ventricular Function in Right Univentricular Stimulation at Different Positions.Cardiac resynchronization therapy when no lateral pacing option exists: vectorcardiographic guided non-lateral left ventricular lead placement predicts acute hemodynamic response.Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.Comparison between endocardial and epicardial cardiac resynchronization in an experimental model of non-ischaemic cardiomyopathy.Optimization of coronary sinus lead placement targeted to the longest right-to-left delay in patients undergoing cardiac resynchronization therapy: The Optimal Pacing SITE 2 (OPSITE 2) acute study and protocol.Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration.Impact of the Right Ventricular Lead Position on Clinical End Points in CRT Recipients--A Subanalysis of the Multicenter Randomized SPICE Trial.Active fixation of a thin transvenous left-ventricular lead by a side helix facilitates targeted and stable placement in cardiac resynchronization therapy.Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study.Left Ventricular Lead Placement Targeted at the Latest Activated Site Guided by Electrophysiological Mapping in Coronary Sinus Branches Improves Response to Cardiac Resynchronization Therapy.Clinical and echocardiographic response of apical vs nonapical right ventricular lead position in CRT: A meta-analysis.Up-to-date cardiac resynchronization therapy.Impact of basal inferolateral scar burden determined by automatic analysis of 99mTc-MIBI myocardial perfusion SPECT on the long-term prognosis of cardiac resynchronization therapy.Localization of pacing and defibrillator leads using standard x-ray views is frequently inaccurate and is not reproducible.The use of quadripolar left ventricular leads improves the hemodynamic response to cardiac resynchronization therapy.Multipoint left ventricular pacing in a single coronary sinus branch improves mid-term echocardiographic and clinical response to cardiac resynchronization therapy.Three-dimensional echocardiography with left ventricular strain analyses helps earlier prediction of right ventricular pacing-induced cardiomyopathy.Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization TherapyLong-Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular PacingLeft Ventricular Three-Dimensional QuadripolarLeadAcuteClinical Study: TheLILACStudy
P2860
Q28087763-3A6A6467-7C87-46CB-B55C-E1A35B39513EQ30392124-B83BA4C7-DFA2-4C23-B70B-A1C2EFD98790Q33162947-F72D613B-F22A-4587-AAE1-CC3BE6FD8895Q35139951-1A657E2E-56A7-41E2-B5F6-FB8AED490D53Q35204458-B5D69F4F-A75D-4F67-BF8F-EE96F894CB8FQ35591597-C06B33A4-CA3E-4F91-9112-48691BF70D9BQ36458928-CD26B95C-BECE-41BD-AD2A-CB3F3E27984CQ36895752-973D0E94-9770-452E-A4DB-2A006CA1E040Q38118162-25869730-BF0C-4703-8704-CAB142C08272Q38220694-9E80DD86-C1B8-4A0A-9DE9-96C11D4ABACBQ38258658-F78C56A4-8C48-4105-BBE5-F47B6C27FD02Q38452103-6D0EAE04-773A-4E3A-9176-0AE70B7DF02EQ38884026-8FD14CCC-655E-430B-9655-D24B573D996BQ41634335-6F7F1B46-1AEC-43F1-9B9D-1C18060D8B61Q43483584-801DABF1-BB39-4E22-9412-7EAE09AA9D38Q44015848-95FA4F1A-99E6-46E4-914E-A19CBD524FF2Q44274746-ED899571-AF18-404D-A38F-777690FE4D70Q47113785-B5A452CC-BA90-43D1-B885-5B829C5955E6Q47440524-E589D770-97ED-441D-AE46-9D966359CB87Q47440692-4F85E799-0693-44C3-AAB7-6F87A5D55474Q47827623-4A9EC2C9-BAC9-46CB-AD38-526B54C8BEF5Q48201700-6D25A0CA-D69E-4A4C-AEDB-04D94F72D022Q48540226-C8F9D366-1918-4B41-88CD-659807D6C9C9Q50801504-23F7962A-7B1D-41A8-B9E0-EF780EBBC7E2Q51615824-58F0A873-E2DF-4B7D-8EA3-F8091785E7D4Q51695498-F65620F6-CEC7-426E-AF13-23B2EB032018Q51718483-41892A84-1209-43B3-A3CD-365570F1ED9FQ51819101-1207E5AE-F2FE-4E06-8AC9-4976425C6EDEQ52587214-ED973FB6-F733-4634-AA8E-206968B5C89BQ52741625-74BB2F49-0D45-496E-854D-3AA2D327E557Q52944811-979384F8-3144-4511-B66E-CAAAB9A391A0Q53166362-D535828A-FC6D-4603-A26D-E0B69F6F62D3Q53364594-AB6656C1-ACA8-4419-AD28-1A9E05D0536CQ53477060-EB373481-9926-45D1-844B-6E0AA9BF6797Q55317231-D06359B2-E679-4BA4-AA5A-510C6759FDCDQ57824386-E6A6CB9B-96B3-4BDB-B7AA-C849DFFFC47DQ58129773-C6DD5543-1CF1-4EC5-A8A8-39C82F77881DQ58851419-C528F575-365C-49AC-BD6F-92FAD40E9682
P2860
Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sites of left and right ventri ...... ations from the REVERSE trial.
@en
type
label
Sites of left and right ventri ...... ations from the REVERSE trial.
@en
prefLabel
Sites of left and right ventri ...... ations from the REVERSE trial.
@en
P2093
P2860
P356
P1476
Sites of left and right ventri ...... ations from the REVERSE trial.
@en
P2093
Bart Gerritse
Catherine Meunier
Christophe Thébault
Erwan Donal
J-Claude Daubert
Michael R Gold
REVERSE study group
Renaud Gervais
William T Abraham
P2860
P304
P356
10.1093/EURHEARTJ/EHR505
P577
2012-01-26T00:00:00Z